جستجوی استاد راهنمای دانشگاهی

Dr. Camila Aquino serves as Assistant Professor in both the Department of Clinical Neurosciences and Department of Community Health Sciences at the University of Calgary's Cumming School of Medicine, and is a Full Member of the Hotchkiss Brain Institute. As Medical Director of the Deep Brain Stimulation Program, she specializes in Parkinson's disease, essential tremor, dystonia, and chorea management, including EMG-guided botulinum toxin injections. Her educational background includes: M.D. in Medicine from Escola Superior de Ciencias da Santa Casa (2005) M.S. in Neurosciences from Federal University of Sao Paulo (2012) Ph.D. in Neurosciences from Federal University of Sao Paulo (2019) M.S. in Health Research Methods, Clinical Epidemiology from McMaster University (2020) Dr. Aquino's research addresses unmet needs in movement disorders through innovative clinical trial designs for Parkinson's disease, focusing on precision-medicine approaches, early intervention, and outcome optimization. She actively evaluates neuromodulation therapies including Deep Brain Stimulation, Spinal Cord Stimulation, and MRgFUS, with emphasis on expanding indications and improving patient outcomes. As an International Parkinson and Movement Disorder Society member, she chairs the web-based learning committee and serves on evidence-based medicine and outcome measure committees. Analysis of her 15 most recent publications (2021-2025) reveals a cohesive research trajectory centered on Parkinson's disease management, with dominant themes in motor fluctuation treatments, deep brain stimulation methodology, and clinical trial innovation. Her work bridges fundamental clinical practice guidelines with advanced neuromodulation technologies, demonstrating consistent commitment to evidence-based solutions for movement disorders. Her scientific recognition includes: Parkinson Canada research grant Mohammed Al Zaibak Foundation scholarship CAPES scholarship from Brazilian Ministry of Education Dr. Aquino has secured significant research funding supporting clinical trials in Parkinson's disease neuroprotection and neuromodulation therapies. While specific student advisees aren't listed, her leadership of the DBS Program and active clinical trial portfolio indicate substantial mentorship responsibilities. Her grant portfolio emphasizes translational research with direct clinical impact. She directs the University of Calgary's Deep Brain Stimulation Program and contributes to the MRI-guided focused ultrasound initiative. Through her International Parkinson and Movement Disorder Society committee roles, she shapes global educational standards and evidence-based practices in movement disorders.

• Movement Disorders
• Parkinson's Disease
• Deep Brain Stimulation
• +۵ مورد دیگر

Professor Simon Fraser is a public health physician and academic at the University of Southampton , specializing in kidney disease and multimorbidity. His work integrates epidemiology, health literacy, and inequality analysis to address chronic disease burdens. Educational Background: BM (University of Southampton, 1992) MSc in Public Health DM (Doctor of Medicine, 2014) Research Focus: Fraser's research spans kidney disease , multimorbidity , treatment burden , and health inequalities . Recent projects include the NURTuRE-CKD HRQoL Study and MELD-B , examining determinants of chronic disease progression and intervention design. Academic Contributions: His publications from 2024-2025 emphasize electronic health records for multimorbidity analysis, neonatal risk factors for adult comorbidity, and deprescribing strategies for older adults. Collaborations include NIHR Applied Research Collaboration Wessex and Kidney Research UK. Scientific Recognition: Fellow of the Faculty of Public Health (FFPH) Member of the Royal College of General Practitioners (MRCGP) Fellow of the Higher Education Academy (FHEA) Mentorship: Current PhD students include Emilia Mary Holland and Keegan Guan Ru Lee . He co-leads projects with leading researchers in public health and nephrology.

• Healthcare
• Public Health
• Kidney Disease
• +۳ مورد دیگر

Pan Xu is a tenure-track assistant professor with joint appointments in the Department of Biostatistics & Bioinformatics, Department of Computer Science, and Department of Electrical & Computer Engineering at Duke University. Previously, Xu was a Postdoctoral Scholar Research Associate at Caltech's Department of Computing and Mathematical Science and earned a Ph.D. in Computer Science from UCLA. Xu's research focuses on developing computationally- and data-efficient machine learning algorithms with strong empirical performance and theoretical guarantees. Xu's research interests center around Machine Learning with broad applications in Artificial Intelligence, Data Science, Optimization, Reinforcement Learning, and High Dimensional Statistics. The research specifically targets real-world problems in Bioinformatics and Healthcare, with recent work emphasizing distributionally robust decision making, efficient exploration strategies, and multi-agent systems. Xu has developed novel algorithms that address the challenges of exploration in sequential decision making and robustness to distributional shifts between training and deployment environments. Xu's recent publications demonstrate a strong trend toward developing theoretically grounded yet practical algorithms for reinforcement learning and bandit problems, with particular emphasis on distributionally robust methods, efficient exploration techniques, and applications to healthcare. The work spans both theoretical analysis (providing minimax optimal regret bounds) and practical implementations (validated on benchmarks like Atari games and real healthcare datasets). Whitehead Scholar award from Duke University School of Medicine (2023) Best Paper Award at ACM FAccT 2023 for Queer In AI paper PIMCO Postdoctoral Fellowship in Data Science (2022) TMLR Featured Certification (2023) NSF award on approximate sampling based exploration (2023) Xu actively mentors multiple Ph.D. students across Duke's Biostatistics & Bioinformatics, Computer Science, and Electrical & Computer Engineering programs, with several alumni now pursuing doctoral studies at top institutions. The research group has secured competitive funding including an NSF award for approximate sampling based exploration for sequential decision making. Xu serves as an action editor for TMLR and as an area chair for major conferences including ICML, NeurIPS, AAAI, ICLR, and AISTATS. Xu leads a dynamic research group focused on sequential decision making, with projects spanning theoretical algorithm development, implementation of practical systems, and applications to healthcare and bioinformatics. The group maintains active collaborations across Duke's medical and engineering schools, with recent work applying machine learning to epidemic forecasting during the pandemic.

• Machine Learning
• Artificial Intelligence
• Data Science
• +۷ مورد دیگر

Janani Thillainadesan is an NHMRC Senior Research Fellow at the Sydney Medical School/Concord Clinical School and the Centre for Education and Research on Ageing, affiliated with the Faculty of Medicine and Health at the University of Sydney. She is also a member of the Charles Perkins Centre. Her research focuses on optimizing healthcare delivery for older adults, particularly in geriatric surgery, perioperative care, and dementia interventions. Key research areas include frailty assessment, deprescribing strategies, collaborative care models, and leveraging technology (e.g., mobile health) in geriatric medicine. She has contributed to multidisciplinary studies involving clinical datasets, quality indicators, and mixed-methods analyses of patient experiences and care expectations. Awards: 2023 RACP Vincent Fairfax Research Fellowship 2021 ANZSGM Career Investigator Prize 2021 UK Age Anaesthesia Association Best Oral Presentation Prize 2019 Evidence Based Perioperative Medicine Asia Congress Runner Up Prize Her work bridges clinical practice, education, and policy through grants like the 2024 electronic frailty index project. Media engagement includes a 2019 Studio 10 segment highlighting her contributions to aging-related healthcare innovations.

• Health services for older people
• Collaborative models of care
• Frailty
• +۴ مورد دیگر

Preet Singh is a Professor and Associate Chair for Graduate Studies in the School of Materials Science and Engineering at Georgia Tech, with affiliations to the College of Engineering. His research focuses on corrosion science, electrochemistry, and environmental degradation of materials, particularly metals and alloys. Prior to joining Georgia Tech in 2003, he was a faculty member at the Institute of Paper Science and Technology (IPST), where he investigated corrosion issues in the pulp and paper industry. Professor Singh's work explores fundamental mechanisms of material degradation in industrial environments, aiming to develop mitigation strategies against environment-induced failures. Key research areas include corrosion fatigue, hydrogen embrittlement, stress corrosion cracking, and oxidation behavior. His group employs experimental approaches to study material reliability under varying chemical and mechanical conditions. Recent publications demonstrate interdisciplinary collaboration across oncology, agriculture, and energy systems, reflecting broad applications of materials science principles. Research trends show increased focus on biomedical materials and sustainable technologies alongside core corrosion studies. Professor Singh advises graduate students including Abdullah Alzubail, Yousif Al Rabie, Sai Shreeya, Yara, and Sean Li. He directs the Corrosion and Materials Reliability Laboratory (CMCRL), which partners with industry to solve practical engineering challenges related to material performance.

• Corrosion Science
• Electrochemistry
• Metals and Alloys
• +۵ مورد دیگر

Eileen Klein is an Associate Professor of Social Work and Convener of the BSW Program at Ramapo College of New Jersey's School of Social Science and Human Services. Her work focuses on LGBTQ mental health treatment , community support systems , and policy reform for marginalized populations. Klein has presented extensively at international conferences on topics like cultural competency in social work education and LGBTQ health disparities . Ph.D., M.S., and M.S.W. from New York University and SUNY Buffalo Key research areas: LGBTQ Mental Health, Community Health Disparities, Forensic Social Work Published 15+ works (2013-2021) on topics ranging from polypharmacy to support programs for LGBTQ clients Active in professional development: Delivered presentations at conferences across the U.S. and Italy on topics including integrated treatment and supervision of student interns

• Community Mental Health
• LGBTQ Mental Health Treatment
• Social Work Policy Advocacy
• +۳ مورد دیگر

Dr. Kenji Fujita is a Research Fellow at the Kolling Institute, University of Sydney, specializing in ageing, pharmacology, and pharmaceutical care quality. He holds a PhD, MScMed (ClinEpid), and BPharm from the University of Sydney. Previously a pharmacist in Japan, he leads international initiatives in the Pharmaceutical Care Network Europe (PCNE) and the International Pharmaceutical Federation (FIP). His work focuses on deprescribing strategies, polypharmacy, and developing quality indicators for healthcare services. Dr. Fujita’s research integrates big data analysis, statistical modeling, and machine learning to address challenges in geriatric pharmacotherapy. Current projects include validating frailty indices, evaluating deprescribing interventions in older adults, and developing NLP tools for clinical documentation analysis. He has also contributed to assessing organizational readiness for guideline implementation in community pharmacies. Awards include the 2023 Outstanding Poster Presentation Award at the IAGG Asia/Oceania Congress and 2022 Best Poster at the Japanese Society of Social Pharmacy. He has secured grants such as the 2024 electronic frailty index project and the 2021 systems-approach to medication review initiative. Dr. Fujita collaborates with global networks like J-HOP (Japan Home Visiting Pharmacy Association) and leads multidisciplinary teams across Australia and Europe. His lab focuses on translating data-driven insights into actionable clinical practices to improve medication safety and quality in ageing populations.

• Healthy Ageing
• Pharmacology
• Pharmacoepidemiology
• +۳ مورد دیگر

Professor David Alldred is a Professor of Medicines Use and Safety at the University of Leeds' School of Healthcare, within the Faculty of Medicine and Health. His expertise spans medicines optimisation, patient safety, deprescribing, and care home medication management. He leads key research initiatives such as the NIHR Yorkshire and Humber Patient Safety Research Collaboration's 'Decluttering Safely for Safety' theme and co-leads the School of Healthcare's Quality and Safety research theme. Education: PhD (clinical research on care home medication review), MSc in Clinical Pharmacy, PGCert in Learning and Teaching, and BPharm (Hons). Professional memberships include Fellowships of the Royal Pharmaceutical Society and the Higher Education Academy. Research focuses on improving medication use for older adults in care homes and underserved populations, employing systematic reviews, qualitative studies, and RCTs. Notable projects include the CHUMS study (Department of Health-funded medication error analysis in care homes) and leadership roles in NIHR Programme Grants like CHIPPS and CHARMER. He collaborates with NHS England to implement medicines optimisation programs and co-designed multilingual medication review resources to reduce health inequalities. Awards include the Pharmacy Practice UK Research Award (2015) and NIHR Senior Investigator status (2025). His work emphasizes translating evidence into clinical practice, with over 150 publications and supervising NIHR-funded doctoral students in critical care, diabetes, cystic fibrosis, and geriatrics. Led the Care Homes' Use of Medicines Study (CHUMS), contributed to NICE guidelines for care home medicines management, and developed interventions like the Medicines at Transitions Intervention (MaTI) for heart failure patients. His research themes address polypharmacy reduction, medication safety across care transitions, and pharmacist-led deprescribing strategies.

• Medicines Optimisation
• Patient Safety
• Deprescribing
• +۵ مورد دیگر

Nashwa Masnoon is a Postdoctoral Research Fellow in Geriatric Pharmacotherapy at the Kolling Institute, part of the Faculty of Medicine and Health at the University of Sydney. She is also a hospital pharmacist at the Royal North Shore Hospital. Her academic background includes a BPharm(Hons) and a PhD from the University of South Australia, where her doctoral work focused on identifying risks of adverse outcomes from polypharmacy in older adults with multimorbidity. Dr Masnoon’s research interests span geriatric pharmacology, deprescribing practices, pharmacoepidemiology, and quality use of medicines. Her current projects include developing stewardship programs for anticholinergic/sedative deprescribing, optimizing medication use in hospitals for older patients, and educating hospital pharmacists using the Drug Burden Index intervention bundle. She has co-supervised Honours students in 2022 and 2023, focusing on deprescribing in hospital settings and patient-reported experiences post-intervention. Research Themes: Healthy Ageing Key Approaches: Systematic reviews, clinical interventions, pharmacoepidemiological analysis Dr Masnoon has received notable awards including the 2023 FMH Showcase Travel Award, Royal North Shore Hospital Travel Fellowship (2023), and a 2017 People’s Choice Award for her 3 Minute Thesis presentation. Her work emphasizes improving medication outcomes through evidence-based deprescribing and precision medicine approaches. She is affiliated with the Australasian Pharmaceutical Science Association (APSA), International Pharmaceutical Federation (FIP), and Australian Deprescribing Network (ADeN). Her grants include the 2024 electronic frailty index project and a 2022 travel award-funded initiative.

• Geriatric Pharmacology
• Deprescribing
• Pharmacoepidemiology
• +۳ مورد دیگر

Dr. Lauren Cirrincione is an Associate Professor in the Department of Pharmacy at the University of Washington School of Pharmacy in Seattle, Washington. Her academic appointment is within the Department of Pharmacy, which is part of the School of Pharmacy at the University of Washington. Dr. Cirrincione earned her Doctor of Pharmacy (PharmD) degree from the University of Pittsburgh School of Pharmacy and a Master of Public Health (MPH) in epidemiology from the University of Nebraska Medical Center. She completed a clinical pharmacology fellowship in HIV at the University of Nebraska Medical Center. Dr. Cirrincione's research program addresses mechanisms of hormone-mediated drug interactions, with a primary focus on clinical, translational pharmacology in transgender medicine. Her expertise spans Infectious Diseases, Mechanisms of Drug Interactions, Pharmacokinetics-Pharmacodynamics, Transgender and Gender Diverse Research, and Translational Research. Her work examines how gender-affirming hormone therapy interacts with other medications, particularly antiretrovirals, and investigates the clinical implications of these interactions for transgender patients. She has made significant contributions to understanding estradiol concentrations in gender-affirming therapy, kidney function assessment in gender-diverse populations, and the inclusion of transgender individuals in clinical trials. Her publications demonstrate a consistent focus on improving pharmacological care for transgender and gender-diverse individuals, with recent work examining adolescent transgender medicine, psychotropic medication interactions, and self-injection experiences among transgender people on hormone therapy. Her research bridges clinical pharmacology with gender-affirming care, addressing critical gaps in evidence-based practice for this population. Dr. Cirrincione teaches PHRMCY 535: Pharmacotherapeutics V at the University of Washington School of Pharmacy. Her scientific contributions have advanced the field of transgender pharmacology, with particular emphasis on clinical applications and evidence-based approaches to medication management for transgender patients.

• Infectious Diseases
• Mechanisms of Drug Interactions
• Pharmacokinetics-Pharmacodynamics
• +۵ مورد دیگر

Dr. Guangyao Li is a Research Fellow in the Department of Applied Mathematics and Theoretical Physics (DAMTP) at the University of Cambridge, affiliated with the Quantum Fluids research group. His work focuses on theoretical and computational studies of quantum fluids, particularly exciton-polaritons in semiconductor microcavities and their interactions with electrons and photons. His research bridges condensed matter physics, quantum optics, and nanotechnology. Dr. Li's interdisciplinary interests also extend to pharmacology and clinical medicine, evidenced by collaborative studies on drug efficacy, drug-related problems in hospital settings, and guidelines for off-label drug use in ophthalmology. These studies address topics such as glucocorticoid therapy complications, proton pump inhibitor utilization, and anti-vascular endothelial growth factor treatments for ocular diseases. His quantum physics publications explore polariton scattering, Bose-Einstein condensates, and chiral edge states in quantum fluids. Recent medical studies analyze drug safety, self-monitoring in diabetes, and inappropriate medication use in elderly cardiac patients. These works highlight his dual contribution to fundamental physics research and applied clinical pharmacology. No academic awards or grants are explicitly stated in available records. He advises no known students but collaborates across disciplines in Cambridge and Chinese medical institutions. His research is conducted within the Quantum Fluids group at DAMTP, leveraging advanced theoretical models and computational simulations.

• Quantum Physics
• Condensed Matter Physics
• Theoretical Physics
• +۴ مورد دیگر

Ana Cristina Manso serves as Associate Professor, Vice-Rector, and Member of the Scientific Council at Egas Moniz University Institute. She directs multiple Preventive and Community Dentistry courses within the Integrated Master's Degree in Dentistry program and serves as a researcher at the Egas Moniz Interdisciplinary Research Center. Her clinical practice includes work at the Oral Health Unit - Clinical Center at the Bankers' Union of the South and Islands. Her educational background includes a PhD in Research in Stomatology (2008) from the University of Granada and a Dentistry Degree (1993) from the Higher Institute of Health Sciences South. She has completed numerous specialized trainings including Pedagogical Training, Quality Assurance Systems, and Social Responsibility seminars at Egas Moniz. Manso's research focuses on geriatric oral health, preventive dentistry, and community-based dental care. Her work examines self-perception of oral health among elderly populations using tools like GOHAI, investigates halitosis treatments including cinnamon-based solutions, and studies caries prevention through remineralization techniques. She has published extensively on dental erosion, temporomandibular disorders, and socioeconomic factors affecting oral health outcomes in Portuguese populations. Her recent publications reveal strong trends in geriatric dentistry and health disparities research, with significant focus on oral health literacy, socioeconomic determinants of oral health, and interdisciplinary approaches to managing conditions like xerostomia and temporomandibular disorders. Methodologically, her work combines clinical trials, cross-sectional analyses, and systematic reviews. Manso has supervised 57 master's dissertations (co-supervising 20), 1 doctoral thesis (co-supervised), and 2 undergraduate theses. Her research projects include ADAPTAR - Projeto EduCom and the Egas Moniz Interdisciplinary Research Center (UID/BIM/04585/2019). She actively participates in quality assurance initiatives as a Member of the Quality Assurance Commission for Egas Moniz Teaching. As Director of the Egas Moniz Interdisciplinary Research Center, she leads research on community dentistry and oral health promotion. Her work extends to social responsibility initiatives including oral health programs for prison populations and elderly community outreach through the 'Primeiro Dente, Primeira escovagem' program.

• Oral Health
• Geriatric Dentistry
• Dental Caries
• +۷ مورد دیگر

Rafael Perera is a Professor of Medical Statistics at the Nuffield Department of Primary Care Health Sciences (NDPCHS), University of Oxford, where he has been since 2002. He holds leadership roles as Director of the Statistics Group and Director of Graduate Studies , overseeing academic leadership and methodological research. He is also a Statistical Editor of BMJ and BMJ Medicine , and a fellow at St Hugh’s College Oxford . Education : DPhil, MSc, MA Rafael’s research focuses on monitoring for managing long-term conditions (e.g., Type 2 diabetes, hypertension) and complex multimorbidity phenotypes . His work includes impact of extreme temperatures on health , meta-analysis methods , and methodology for infectious diseases . He leads large methodological groups and has been a PI on NIHR-funded infrastructure programs (BRC, ARC, MIC). Recent publications highlight his expertise in clinical prediction models , digital health interventions , and diagnostic test evaluation . His grants span applied research , global health transformation , and ageing research . Scientific Awards : National and international recognition for methodology development in clinical trials (NIHR Progress Report 2008/09) Rafael supervises DPhil and MSc students and leads a fully accredited Clinical Trials Unit . His editorial and policy influence extends to healthcare policy panels and the Centre for Evidence-Based Medicine as Director of Research Methodologies.

• Medical Statistics
• Primary Care Health Sciences
• Monitoring of Long-Term Conditions
• +۶ مورد دیگر

Professor Alan Winston serves as Professor of Genito-Urinary Medicine within the Department of Infectious Disease at Imperial College London's Faculty of Medicine. He concurrently holds a Consultant Physician position at St. Mary's Hospital, London, where he directs the HIV and GU clinical trials unit managing over 20 active studies. His clinical and academic work bridges patient care with cutting-edge research in HIV comorbidities. Winston qualified from Glasgow University and completed specialized training in general medicine and HIV care across the UK and Australia. This foundation supports his current focus on non-infectious complications in the modern antiretroviral era, particularly neurological and mental health aspects. His research prominently explores central nervous system complications in HIV, cognitive impairment mechanisms, and mental health disparities including depression and anxiety. He investigates multimorbidity patterns in aging HIV populations and develops person-centered approaches to reduce stigma. His work integrates clinical trials, cohort studies like POPPY, and mixed-methods research to address quality-of-life challenges beyond viral suppression. Analysis of his 2024-2025 publications reveals three dominant trends: (1) neurocognitive effects of specific antiretrovirals (dolutegravir, bictegravir), (2) psychosocial determinants of cognitive performance, and (3) systemic barriers in mental healthcare access for HIV patients. The POPPY cohort study serves as a critical data source across multiple publications examining aging, polypharmacy, and multimorbidity. Winston leads the POPPY study tracking comorbidities in HIV-positive individuals over time and directs the St. Mary's clinical trials unit conducting therapeutic research. His team includes clinical project managers, trials coordinators, and research staff like PhD candidate Merle Henderson. While specific grants aren't detailed, his management of 20+ concurrent studies indicates substantial research funding from sources including European AIDS Clinical Society collaborations. His laboratory and clinical operations are centered at the Winston Churchill Wing of St Mary's Campus, with affiliations to the Section of Virology and St Mary's Clinical Trials Centre. He contributes to European guideline development, notably statin use recommendations for cardiovascular prevention in HIV patients.

• HIV
• Central Nervous System Complications
• Mental Health
• +۵ مورد دیگر

Associate Professor Stephen Carter is an Associate Professor in Pharmacy Practice at the University of Sydney's Sydney Pharmacy School within the Faculty of Medicine and Health. He serves as the Program Director for Undergraduate Pharmacy programs and is a registered pharmacist with clinical specialisation in medication management review. Stephen holds qualifications including BPharm, MSc, PhD, and Grad Cert Edu (Higher Ed). He is a Fellow of the Pharmaceutical Society of Australia (FPS), Fellow of the Higher Education Academy (FHEA), and holds other professional accreditations. His research focuses on optimizing the role of pharmacists in healthcare, particularly examining how consumers and caregivers obtain and use medicines, designing effective pharmacist services, and supporting pharmacists throughout their professional journey. His work spans areas including osteoporosis care, medication adherence, service quality in community pharmacies, and the application of advanced statistical methods like Structural Equation Modelling. Stephen's publications demonstrate a strong focus on practical pharmacy interventions, with significant work on osteoporosis management services, perinatal depression screening in pharmacies, and digital health approaches to improve medication adherence. His research employs diverse methodologies including randomized controlled trials, qualitative studies, and advanced psychometric analyses. Early Career Investigator Award Australasian Pharmaceutical Science Association (APSA) for 2017 Lesmuller Award for Best Oral Communication - Pharmaceutical Care Network Europe Working Conference, Berlin, 2013 Recipient of the 2013 Annual Best Paper Award by Elsevier publication, Research in Social and Administrative Pharmacy Best Poster Presentation Award: International Social Pharmacy Workshop, Boston, USA, 2014 Top reviewer, Research in Social and Administrative Pharmacy (2015, 2016, 2017, 2019) Stephen actively supervises several graduate students including PhD candidates Fatima Rezea, Steven Tran, Veronika Seda, Kingston Leung, and Joel Hillman, as well as MPhil student Linda Krogh. He has secured significant research funding, including co-leading a $2.36 million Randomized Controlled Trial and managing four current competitive grant-funded projects totaling over $6.3 million. His work has particular emphasis on translating research into practical pharmacy services that improve patient outcomes. Stephen is actively involved in major research initiatives including the #STOP trial (Safer medicines To reduce falls and refractures for OsteoPorosis) and the TICTOC trial (Timely post-discharge medication reviews to Improve Continuity – the Transitions Of Care stewardship), both focusing on innovative pharmacist-led interventions to improve medication safety and effectiveness.

• Pharmacy Practice
• Medication Management
• Osteoporosis Care
• +۷ مورد دیگر